Professor Mark Engelman is an intellectual property barrister and Head of IP at Hardwicke. He is a research associate at St Edmunds College, Cambridge, Adjunct Professor of Law at the University of Notre Dame and a Bencher of Gray’s Inn. Before practising at the Bar, Mark was in-house counsel to large corporates and city solicitors, and a director of Alexander McQueen. He has a BSc in pharmacology.
Foreign patents could prevent UK citizens accessing treatment for COVID-19, warns Professor Mark Engelman
Now is the time to tackle inappropriate behaviour at the Bar as well as extend our reach and collaboration with organisations and individuals at home and abroad
A comparison – Dan Monaghan, Head of DWF Chambers, invites two viewpoints
And if not, why not? asks Louise Crush of Westgate Wealth Management
Marie Law, Head of Toxicology at AlphaBiolabs, discusses the many benefits of oral fluid drug testing for child welfare and protection matters
To mark International Women’s Day, Louise Crush of Westgate Wealth Management looks at how financial planning can help bridge the gap
Casey Randall of AlphaBiolabs answers some of the most common questions regarding relationship DNA testing for court
